1-13 of 13
Xinping Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Small-Dose Trimethoprim-Sulfamethoxazole Prevents Pneumocystis Jiroveci Pneumonia in B-Cell Lymphoma Patients Receiving Chemotherapy: Analysis of a Randomized Controlled Clinical Trial

Chunxiao Liu, Xuewu Zhang, Yanan Zhu, Feng Xiao, Yunfei Lv, Xingnong Ye, Xia Li, Juying Wei, Huafeng Wang, Yile Zhou, Hongyan Tong, Xinping Zhou, Chunmei Yang, Liping Mao, De Zhou, Li Zhu, Xiaolong Zheng, Li Ye, Liangshun You, Jie Jin, Wenjuan Yu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6314.
https://doi.org/10.1182/blood-2023-189933
Published: 2023
Journal Articles

Safety and Efficacy of Selinexor Sequential Azacytidine in Newly Diagnosed Patients with Myelodysplastic Syndromes EB1 or EB2: A Single-Center, Single-Arm, Phase Ib/II Trial

Liya Ma, Wenli Yang, Xinping Zhou, Li Ye, Gaixiang Xu, Chao Hu, Yingwan Luo, Chunmei Yang, Zheng Ge, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 1856.
https://doi.org/10.1182/blood-2023-183101
Published: 2023
Journal Articles

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Gaixiang Xu, Wei Wang, Shuanghong Zhu, Kongfei Li, Xinping Zhou, Liya Ma, Li Ye, Chen Mei, Lu Wang, Lingxu Jiang, Haitao Meng, Wen-Juan Yu, Jie Jin, Hongyan Tong, Jian Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6481.
https://doi.org/10.1182/blood-2023-184789
Published: 2023
Journal Articles

High Expressions of Checkpoint Receptors in T Cells Subsets of Myelodysplastic Syndromes Patients with TP53 Mutations

Lingxu Jiang, Xin Huang, Xinping Zhou, Li Ye, Lu Wang, Chen Mei, Liya Ma, Gaixiang Xu, Chao Hu, Ziyang Zhou, Xiaozhen Liu, Yueyuan Han, Zheng Ge, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 4614.
https://doi.org/10.1182/blood-2023-182601
Published: 2023
Journal Articles

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, Yile Zhou, Xiaolong Zheng, Xinping Zhou, Yanling Ren, Liya Ma, Gaixiang Xu, Chunmei Yang, Huafeng Wang, De Zhou, Min Yang, Xingnong Ye, Juying Wei, Wen-Juan Yu, Jiejing Qian, Yinjun Lou, Wanzhuo Xie, Jian Huang, Haitao Meng, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2023-184470
Published: 2023
Journal Articles

The M6A Methyltransferase METTL14 Promotes Myelodysplastic Syndromes Development Via PI3K/Akt Signaling Pathway

Lingxu Jiang, Xinping Zhou, Chao Hu, Chen Mei, Gaixiang Xu, Liya Ma, Yanling Ren, Li Ye, Lu Wang, Yingwan Luo, Jie Jin, Jie Sun, Hongyan Tong
Journal: Blood
Blood (2022) 140 (Supplement 1): 6894–6895.
https://doi.org/10.1182/blood-2022-165203
Published: 2022
Journal Articles

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Jianai Sun, Yi Xu, Min Yang, Huafeng Wang, Wenjuan Yu, Liangshun You, Haitao Meng, Chunmei Yang, Xinping Zhou, Li Li, De Zhou, Xiujing Ye, Hong-hu Zhu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Journal: Blood
Blood (2022) 140 (Supplement 1): 3756.
https://doi.org/10.1182/blood-2022-158723
Published: 2022
Journal Articles

EZH2 Inhibition Mediates Proptosis Via DHX9 and S100A9 in Myelodysplastic Syndromes

Qi Zhang, Wei Lang, Lu Wang, Wenli Yang, Yingwan Luo, Shuanghong Zhu, Lingxu Jiang, Yuxia Wang, Chen Mei, Xinping Zhou, Yanling Ren, Liya Ma, Li Ye, Xingnong Ye, Gaixiang Xu, Jie Sun, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2022) 140 (Supplement 1): 9767–9768.
https://doi.org/10.1182/blood-2022-165886
Published: 2022
Journal Articles

15-Days Duration of Venetoclax Combined with Azacitidine in the Treatment of Relapsed/Refractory High-Risk Myelodysplastic Syndromes: A Retrospective Single-Center Study

Hongyan Tong, Chen Mei, Yanling Ren, Xinping Zhou, Yingwan Luo, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 12351–12352.
https://doi.org/10.1182/blood-2022-168938
Published: 2022
Journal Articles

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Gaixiang Xu, Shuanghong Zhu, Xinping Zhou, Kongfei Li, Lingxu Jiang, Hongyan Tong, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 9796–9797.
https://doi.org/10.1182/blood-2022-165344
Published: 2022
Journal Articles

Combination of Decitabine and ATRA in Newly Diagnosed Myelodysplastic Syndromes Subtype EB-Interim Analysis of a Multicenter, Randomized, Open-Label Trial

Xinping Zhou, Fanjun Meng, Yanjuan Lin, Zheng Ge, Yuemin Kuang, Lu Wang, Jin Zhang, Hai Cheng, Yan Gao, Yulu Tian, Li Huang, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2021) 138 (Supplement 1): 539.
https://doi.org/10.1182/blood-2021-149326
Published: 2021
Journal Articles

Epigenetic Priming with Decitabine Followed By Low-Dose Idarubicin Plus Cytarabine in AML Evolving from MDS or Higher Risk MDS: A Multicentre Phase 2 Single-Arm Trial

Hongyan Tong, Docter, Xinping Zhou, Chen Mei, Jin Zhang, Ying Lu, Jianping Lan, MD, Shengyun Lin, Yuefeng Zhuang, Yuemin Kuang, Yanling Ren, Liya Ma, Juying Wei, Li Ye, Weilai Xu, Kongfei Li, Chenxi Lu, Jie Jin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2594.
https://doi.org/10.1182/blood-2019-127675
Published: 2019
Journal Articles

The High NRF2 Expression Confers Chemotherapy Resistance through Upregulated DUSP1 in Myelodysplastic Syndromes

Peipei Lin, Yanling Ren, Xinping Zhou, Chen Mei, Chao Hu, Yingwan Luo, Yile Zhou, Xiaomei Yan, Gang Huang, PhD, Hongyan Tong, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2956.
https://doi.org/10.1182/blood.V130.Suppl_1.2956.2956
Published: 2017